Patent Assignment
Reel/Frame 066539/0204
Assignment of Assignor's Interest
Recorded: 2024-02-23
Pages: 3
Assignor
KEMPHARM DENMARK A/S
Executed: 2023-07-05
Assignee
ZEVRA DENMARK A/S
OLE MAALØES VEJ 3, COPENHAGEN N, 2200, DENMARK
Covered Properties
(6)
Use of HSP70 as a Regulator of Enzymatic Activity
Use of HSP70 as a Regulator of Enzymatic Activity
Use of HSP70 as a Regulator of Enzymatic Activity
Use of HSP70 as a Regulator of Enzymatic Activity
Use of HSP70 as a Regulator of Enzymatic Activity
Use of HSP70 as a Regulator of Enzymatic Activity
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 14, 2011
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS C/O COBIS A/S
Reel/Frame 025803/0876 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 025803 Frame 0876. Assignor(S) Hereby Confirms the Assignment.
Mar 28, 2011
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 026034/0761 →
Change of Name
Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Security Interest
Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest
Sep 19, 2019
From: JENSEN, THOMAS KIRKEGAARD; JAATTELA, MARJA H.
To: ORPHAZYME A/S
Reel/Frame 050435/0727 →
Assignment of Assignor's Interest
May 6, 2020
From: JENSEN, THOMAS KIRKEGAARD; JAATTELA, MARJA H.
To: ORPHAZYME A/S
Reel/Frame 052593/0815 →
Assignment of Assignor's Interest
Aug 13, 2020
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 053485/0468 →
Assignment of Assignor's Interest
Aug 13, 2020
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 053485/0472 →
Assignment of Assignor's Interest
Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest
Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Release of Security Interest
Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →